Rozibafusp Alfa (AMG 570)

rozibafusp alfa · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rozibafusp Alfa (AMG 570), covering 2023-04-03 to 2023-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis [Phase 1]